Jim Cramer mentioned the name, so let's check what the charts say about the stock.
DXCM is now trading above the rising 50-day moving average line and the rising 200-day line.
Let's review the charts and indicators.
Here's where aggressive traders could go long.
Avoid the long side of GDRX until we see evidence of a durable bottom.
Moderna has been a winner, but here's why traders should raise stops.
The shares have rolled over the past four months or so.
Avoid the long side for now.
It is becoming hard to find individual value stocks that aren't bid up already, but here is a handful.
The news sent shares of the genome editing company skyward after the stock had been basing for months.